[1]
Yadav, S. et al. 2026. Engraftment Outcome of CRISPR/Cas9-Edited Hematopoietic Stem Cells for Genetic Diseases: A Systematic Review and Meta-Analysis of Preclinical Evidence. Journal of Hematology. 15, 2 (Jan. 2026), 108–128. DOI:https://doi.org/10.14740/jh2190.